Charles Schwab’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.8M | Buy |
|
|||||
|
2025
Q1 | $27M | Sell |
|
|||||
|
2024
Q4 | $22.3M | Buy |
|
|||||
|
2024
Q3 | $25.4M | Buy |
|
|||||
|
2024
Q2 | $18.2M | Buy |
|
|||||
|
2024
Q1 | $14.4M | Buy |
|
|||||
|
2023
Q4 | $10.4M | Buy |
|
|||||
|
2023
Q3 | $7.32M | Buy |
|
|||||
|
2023
Q2 | $11.6M | Buy |
|
|||||
|
2023
Q1 | $8.31M | Buy |
|
|||||
|
2022
Q4 | $3.71M | Buy |
|
|||||
|
2022
Q3 | $2.81M | Buy |
|
|||||
|
2022
Q2 | $2.57M | Sell |
|
|||||
|
2022
Q1 | $7.7M | Buy |
|
|||||
|
2021
Q4 | $10.8M | Buy |
|
|||||
|
2021
Q3 | $5.49M | Buy |
|
|||||
|
2021
Q2 | $12.6M | Buy |
|
|||||
|
2021
Q1 | $6.78M | Buy |
|
|||||
|
2020
Q4 | $4.54M | Buy |
|
|||||
|
2020
Q3 | $4.23M | Buy |
|
|||||
|
2020
Q2 | $1.01M | Buy |
|
|||||
|
2020
Q1 | $310K | Buy |
|
|||||
|
2019
Q4 | $309K | Buy |
|
|||||
|
2019
Q3 | $488K | Buy |
|
|||||
|
2019
Q2 | $442K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $278K | Buy |
|
|||||
|
2017
Q4 | $402K | Buy |
|
|||||
|
2017
Q3 | $234K | Hold |
|
|||||
|
2017
Q2 | $150K | Hold |
|
|||||
|
2017
Q1 | $170K | Hold |
|
|||||
|
2016
Q4 | $291K | Buy |
|